ERBB2 and cancer: In addition, its aggressivity is linked to the ability of these cancer cells to metastasize: approximately 50% of patients with human epidermal growth factor receptor 2-positive (HER2+) BC will develop brain metastases (BM) [4] and rates of BM across all metastatic BC (MBC) are increasing [5].